26 research outputs found
The Role of Exosomal miR-181c-3p Within the Ovarian Tumor Microenvironment
https://openworks.mdanderson.org/sumexp22/1034/thumbnail.jp
Spatially Resolved Transcriptomics Identified Distinct Tumor-Stroma Crosstalk Networks Associated With Chemoresistance in Ovarian Cancer
https://openworks.mdanderson.org/sumexp21/1135/thumbnail.jp
CAF-derived MFAP5 is a novel transcription regulator for immune checkpoint CD47 in ovarian cancer
https://openworks.mdanderson.org/sumexp23/1115/thumbnail.jp
Endogenous glutamine decrease is associated with pancreatic cancer progression
Abstract Pancreatic ductal adenocarcinoma (PDAC) is becoming the second leading cause
of cancer-related death in the Western world. The mortality is very high, which emphasizes
the need to identify biomarkers for early detection. As glutamine metabolism alteration is a
feature of PDAC, its in vivo evaluation may provide a useful tool for biomarker identification.
Our aim was to identify a handy method to evaluate blood glutamine consumption in mouse
models of PDAC. We quantified the in vitro glutamine uptake by Mass Spectrometry (MS) in
tumor cell supernatants and showed that it was higher in PDAC compared to non-PDAC
tumor and pancreatic control human cells. The increased glutamine uptake was paralleled
by higher activity of most glutamine pathway-related enzymes supporting nucleotide and
ATP production. Free glutamine blood levels were evaluated in orthotopic and \u202
The Effects of a Glutamine-Free Diet on Tumor Progression and the Immune Landscape of the Ovarian Tumor Microenvironment
https://openworks.mdanderson.org/sumexp23/1053/thumbnail.jp
Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis
Background & Aims: ARID1A is postulated to be a tumor suppressor gene owing to loss-of-function mutations in human pancreatic ductal adenocarcinomas (PDAC). However, its role in pancreatic pathogenesis is not clear despite recent studies using genetically engineered mouse (GEM) models. We aimed at further understanding of its direct functional role in PDAC, using a combination of GEM model and PDAC cell lines. Methods: Pancreas-specific mutant Arid1a-driven GEM model (Ptf1a-Cre; KrasG12D; Arid1af/f or “KAC”) was generated by crossing Ptf1a-Cre; KrasG12D (“KC”) mice with Arid1af/f mice and characterized histologically with timed necropsies. Arid1a was also deleted using CRISPR-Cas9 system in established human and murine PDAC cell lines to study the immediate effects of Arid1a loss in isogenic models. Cell lines with or without Arid1a expression were developed from respective autochthonous PDAC GEM models, compared functionally using various culture assays, and subjected to RNA-sequencing for comparative gene expression analysis. DNA damage repair was analyzed in cultured cells using immunofluorescence and COMET assay. Results: Retention of Arid1a is critical for early progression of mutant Kras-driven pre-malignant lesions into PDAC, as evident by lower Ki-67 and higher apoptosis staining in “KAC” as compared to “KC” mice. Enforced deletion of Arid1a in established PDAC cell lines caused suppression of cellular growth and migration, accompanied by compromised DNA damage repair. Despite early development of relatively indolent cystic precursor lesions called intraductal papillary mucinous neoplasms (IPMNs), a subset of “KAC” mice developed aggressive PDAC in later ages. PDAC cells obtained from older autochthonous “KAC” mice revealed various compensatory (“escaper”) mechanisms to overcome the growth suppressive effects of Arid1a loss. Conclusions: Arid1a is an essential survival gene whose loss impairs cellular growth, and thus, its expression is critical during early stages of pancreatic tumorigenesis in mouse models. In tumors that arise in the setting of ARID1A loss, a multitude of “escaper” mechanisms drive progression